Cocrystal Pharma (COCP) Long-Term Investments (2010 - 2020)
Cocrystal Pharma (COCP) reported Long-Term Investments of $837000.0 for Q4 2020, up 9.84% on a YoY basis from $762000.0 in Q1 2020, and up 9.84% sequentially from $762000.0 in Q4 2019.
Cocrystal Pharma (COCP) Long-Term Investments (2010 - 2020) Analysis & Trends
Cocrystal Pharma (COCP) has 8 years of Long-Term Investments data on file, last reported at $837000.0 in Q4 2020.
- For the quarter ending Q4 2020, Long-Term Investments rose 9.84% year-over-year to $837000.0; the trailing twelve-month figure through Dec 2020 stood at $837000.0 (up 9.84% YoY), and the FY2020 full-year result was $837000.0, up 9.84% from the prior year.
- Long-Term Investments advanced to $837000.0 in Q4 2020, from $762000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $1.3 million in Q4 2016 to a low of $762000.0 in Q4 2019.
- A 5-year average of $940400.0 and a median of $837000.0 in 2020 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments grew 20.49% in 2016 and decreased 27.36% in 2017, its largest moves.
- Tracing COCP's Long-Term Investments over 5 years: stood at $1.3 million in 2016, then declined by 27.36% to $961000.0 in 2017, then dropped by 14.78% to $819000.0 in 2018, then retreated by 6.96% to $762000.0 in 2019, then grew by 9.84% to $837000.0 in 2020.
- Business Quant data shows COCP's Long-Term Investments at $837000.0 in Q4 2020, $762000.0 in Q4 2019, and $819000.0 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 837,000.00 |
| Dec 31, 2019 | 762,000.00 |
| Dec 31, 2018 | 819,000.00 |
| Dec 31, 2017 | 961,000.00 |
| Dec 31, 2016 | 1.32 Mn |
| Dec 31, 2015 | 1.10 Mn |
| Sep 30, 2011 | 61,335.00 |
| Jun 30, 2011 | 61,335.00 |
| Dec 31, 2010 | 42,677.00 |